AMY BETANCOURT: Open Payments
NPI 1578676904 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$798 in 42 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $411 · 2025 $798
Food & beverage: $798
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 9 | $156 |
| AstraZeneca Pharmaceuticals LP | 5 | $92 |
| PFIZER INC. | 3 | $79 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $72 |
| Astellas Pharma US Inc | 3 | $55 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $54 |
| Dynavax Technologies Corporation | 2 | $48 |
| Phathom Pharmaceuticals, Inc. | 4 | $45 |
| Kowa Pharmaceuticals America, Inc. | 2 | $31 |
| GlaxoSmithKline, LLC. | 2 | $30 |
Products named: MOUNJARO, CAPLYTA, PREVNAR 20, Veozah, JOURNAVX, Heplisav-B, VOQUEZNA, BREZTRI.
Industry payments across CA — which companies pay providers there.
